Union code relating to medicinal products for human use

Vote: Amendment 159 — part 2
Decision: No. 31 of the sitting of 10 Apr 2024
Result: 464 for · 123 against · 11 abstained Adopted · roll call
Date: 10 April 2024, 19:18

More facts (6)

Position: vote 6 of 19 on the decision
Requested by: roll call: ECR · split vote: ECR
Official label: A9-0140/2024 – Pernille Weiss – Amendments by the committee responsible – separate vote – Am 159/2
Text: Report A-9-2024-0140
Dossier: 2023-0132
Vote id: 167878

Position: vote 6 of 19 on the decision
Requested by: roll call: ECR · split vote: ECR
Official label: A9-0140/2024 – Pernille Weiss – Amendments by the committee responsible – separate vote – Am 159/2
Text: Report A-9-2024-0140
Dossier: 2023-0132
Vote id: 167878

Cite this page

The members file includes members in office who did not vote.

Roll-call results (EP)

Link to this page

Result

The vote as recorded by name.

Adopted · 78 % of the votes cast were for.

Part voted on: “that word”

Groups

Members counted in their current group: the view with groups at the date of the vote is not available right now.

Members’ votes by their current group. Majority: the most common position. Clear line: a position with at least two thirds of the group’s votes, otherwise Divided.
Group	For	Against	Abst.	Majority line	Clear line
Patriots	For 1	Against 22	Abst. 3	Majority line Against	Clear line Against
S&D	For 61	Against 0	Abst. 0	Majority line For	Clear line For
EPP	For 78	Against 2	Abst. 0	Majority line For	Clear line For
Greens	For 28	Against 0	Abst. 0	Majority line For	Clear line For
Renew	For 32	Against 5	Abst. 0	Majority line For	Clear line For
The Left	For 13	Against 0	Abst. 0	Majority line For	Clear line For
No group	For 2	Against 1	Abst. 2	Majority line —	Clear line No line
ECR	For 1	Against 22	Abst. 1	Majority line Against	Clear line Against
ESN	For 0	Against 2	Abst. 2	Majority line Tie	Clear line Divided

Countries × groups

How each country’s members of each group voted.

The breakdown by country is not available right now.

Members

Each member’s recorded position — groups as of today: the view with groups at the date of the vote is not available right now.

Show all 598 members

No vote recorded

Members in office that day without a recorded position. No vote recorded is not the same as absent: leave, illness or chairing the sitting look the same.

The list of members without a recorded position is not available right now.

Similar votes

Roll calls that split the chamber the most similarly: r is the correlation of members’ positions, over the members who voted in both. Other votes on the same decision are left out.

Similar votes are not available right now.

Compare with another vote

Groups’ lines side by side, and the members who switched between the two votes.

Connections

This vote’s decision, the other votes on it, and related votes.

No connections found for this vote.

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/votes/2024-04-10/167878
Official sources: Roll-call votes, sitting of 10 April 2024 (European Parliament)
Results of votes, sitting of 10 April 2024 (European Parliament)
Data source: EP Open Data API: vote results of the sitting MTG-PL-2024-04-10
Licensed CC BY 4.0.
Retrieved: 25 September 2026

Cite as

European Parliament (2024). “Amendment 159 — part 2 — Union code relating to medicinal products for human use”. Vote, 10 April 2024. votingId 167878, reference 2023-0132. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/votes/2024-04-10/167878 (retrieved 25 September 2026). Official sources: Roll-call votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV_EN.html; Results of votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2024-04-10, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2024-04-10/vote-results?format=application%2Fld%2Bjson (CC BY 4.0).

BibTeX

@misc{epw-vote-2024-04-10-167878,
  author = {{European Parliament}},
  title = {{Amendment 159 — part 2 — Union code relating to medicinal products for human use}},
  year = {2024},
  date = {2024-04-10},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/votes/2024-04-10/167878}},
  url = {https://news.eu-parl.st-solutions.dev/votes/2024-04-10/167878},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Vote. votingId 167878, reference 2023-0132. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT\_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2024-04-10 (CC BY 4.0)}
}